Development of Rapid Diagnostic Tests for Hantaviruses

汉坦病毒快速诊断测试的开发

基本信息

项目摘要

DESCRIPTION (provided by applicant): The objectives of this research proposal are (1) to develop a rapid and easy-to-use nucleic acid diagnostic test to detect hantaviruses in blood, plasma, or serum of infected individuals and carrier rodents, (2) to develop a rapid diagnostic test to detect hantavirus antibodies in blood, plasma, or serum of infected individuals, (3) to develop a hantavirus nucleic acid discriminatory test, (4) to develop TaqMan-based quantitative assays to estimate hantavirus load in virus infected samples, (5) to develop a flow cytometry assay to detect Sin Nombre virus (SNV) antigen in peripheral blood mononuclear cells (PBMC) of patients with hantavirus cardiopulmonary syndrome (HCPS), (6) to develop inbred sublines of fully homozygous deer mice, and (7) to establish tools to dissect deer mouse cellular immune responses to hantavirus infection. The hantavirus nucleic acid and antibody diagnostic tests should be able to yield results in less than one hour, and will assist in the early detection and follow up of hantavirus infections. The availability of the hantavirus nucleic acid discriminatory assay will allow identification of specific viral isolates involved in hantavirus outbreaks and their possible origins. Methods to accurately quantitate hantavirus load in human patients or in animal models, along with the availability of a flow cytometry-based SNV assay, inbred homozygous deer mice, and methodologies to dissect the deer mouse cellular immune responses to hantavirus will facilitate better understanding, prevention, and treatment of hantavirus infections. This research involves collaborative efforts between Chiron Corporation and the School of Medicine, University of New Mexico. A previous collaboration between the two organizations was initiated in 1994 but discontinued in 1997 when Chiron Corporation withdrew funding for hantavirus diagnostic research, as there was no strategic fit at that time. The information generated from the studies proposed in this task will be crucial for the rapid identification of possible bioterrorism attacks involving hantavirus agents and will be vital to assist the medical and public health organizations to efficiently respond to hantavirus outbreaks and/or threats.
描述(由申请人提供):本研究计划的目标是:(1)开发一种快速、易于使用的核酸诊断试验,以检测汉坦病毒感染者和携带啮齿动物的血液、血浆或血清中的汉坦病毒;(2)开发一种快速诊断试验,以检测感染者血液、血浆或血清中的汉坦病毒抗体;(3)开发汉坦病毒核酸鉴别试验;(4)开发基于taqman的定量分析方法,以估计病毒感染样本中的汉坦病毒载量。(5)建立汉坦病毒心肺综合征(HCPS)患者外周血单个核细胞(PBMC)中Sin Nombre病毒(SNV)抗原的流式细胞术检测方法;(6)建立全纯合鹿小鼠近交系亚系;(7)建立分析鹿小鼠对汉坦病毒感染的细胞免疫反应的工具。汉坦病毒核酸和抗体诊断测试应能够在不到一小时内产生结果,并将有助于汉坦病毒感染的早期发现和随访。汉坦病毒核酸鉴别测定的可用性将允许鉴定与汉坦病毒暴发有关的特定病毒分离株及其可能的来源。准确定量汉坦病毒在人类患者或动物模型中的载量的方法,以及基于流式细胞术的SNV检测、近交纯合子鹿小鼠的可用性,以及解剖鹿小鼠对汉坦病毒的细胞免疫反应的方法,将有助于更好地理解、预防和治疗汉坦病毒感染。这项研究涉及凯龙公司和新墨西哥大学医学院的合作努力。这两个组织以前的合作始于1994年,但1997年停止,当时凯龙公司撤回了对汉坦病毒诊断研究的资助,因为当时没有战略上的契合。本任务中提出的研究所产生的信息对于迅速查明可能涉及汉坦病毒制剂的生物恐怖主义袭击至关重要,对于协助医疗和公共卫生组织有效应对汉坦病毒爆发和/或威胁至关重要。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Recognition of decay accelerating factor and alpha(v)beta(3) by inactivated hantaviruses: Toward the development of high-throughput screening flow cytometry assays.
  • DOI:
    10.1016/j.ab.2010.03.016
  • 发表时间:
    2010-07-15
  • 期刊:
  • 影响因子:
    2.9
  • 作者:
    Buranda T;Wu Y;Perez D;Jett SD;BonduHawkins V;Ye C;Edwards B;Hall P;Larson RS;Lopez GP;Sklar LA;Hjelle B
  • 通讯作者:
    Hjelle B
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sergio Pichuantes其他文献

Sergio Pichuantes的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sergio Pichuantes', 18)}}的其他基金

Development of Rapid Diagnostic Tests for Hantaviruses
汉坦病毒快速诊断测试的开发
  • 批准号:
    7009298
  • 财政年份:
    2003
  • 资助金额:
    $ 96.47万
  • 项目类别:
Development of Rapid Diagnostic Tests for Hantaviruses
汉坦病毒快速诊断测试的开发
  • 批准号:
    6602882
  • 财政年份:
    2003
  • 资助金额:
    $ 96.47万
  • 项目类别:
Development of Rapid Diagnostic Tests for Hantaviruses
汉坦病毒快速诊断测试的开发
  • 批准号:
    6847409
  • 财政年份:
    2003
  • 资助金额:
    $ 96.47万
  • 项目类别:
Development of Rapid Diagnostic Tests for Hantaviruses
汉坦病毒快速诊断测试的开发
  • 批准号:
    6776436
  • 财政年份:
    2003
  • 资助金额:
    $ 96.47万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 96.47万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 96.47万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 96.47万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 96.47万
  • 项目类别:
    Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 96.47万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 96.47万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 96.47万
  • 项目类别:
    Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
  • 批准号:
    10699504
  • 财政年份:
    2023
  • 资助金额:
    $ 96.47万
  • 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
  • 批准号:
    10491642
  • 财政年份:
    2023
  • 资助金额:
    $ 96.47万
  • 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
  • 批准号:
    10782567
  • 财政年份:
    2023
  • 资助金额:
    $ 96.47万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了